Literature DB >> 28743648

Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam.

Trinh Quynh Mai1, Nguyen Thi Van Anh2, Nguyen Tran Hien2, Nguyen Huu Lan3, Do Chau Giang3, Pham Thi Thu Hang3, Nguyen Thi Ngoc Lan3, Ben J Marais4, Vitali Sintchenko5.   

Abstract

BACKGROUND: Mycobacterium tuberculosis strain diversity and drug resistance among people living with human immunodeficiency virus (HIV) in Vietnam have not been described previously.
METHODS: We examined M. tuberculosis isolates from TB/HIV co-infected patients in Ho Chi Minh City, Vietnam. Drug susceptibility testing (DST), spoligotyping and 24-locus Mycobacterial Interspersed Repetitive Unit (MIRU-24 typing) were performed, and the rpoB, katG, inhA and inhA promoter, rpsL, rrs and embB genes were sequenced in all drug resistant isolates identified.
RESULTS: In total, 84/200 (42.0%) strains demonstrated "any drug resistance"; 17 (8.5%) were multi-drug resistant (MDR). Streptomycin resistance was present in 80 (40.0%) isolates; 95.2% (80/84) with "any drug resistance" and 100% with MDR. No rifampicin monoresistance was detected. Of the rifampicin resistant strains 16/18 (88.9%) had mutations in the 81-bp Rifampicin Resistance Defining Region (RRDR) of the rpoB gene. Isoniazid resistance was mostly associated with Ser315Thr mutations in the katG gene (15/17; 88.2%). Beijing (49.0%) and East African Indian (EAI) lineage strains (35.0%; 56/70 EAI-5) were most common.
CONCLUSION: TB/HIV co-infection in Vietnam was associated with high rates of TB drug resistance, although we were unable to differentiate new from retreatment cases. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug resistance; Epidemiology; Mycobacterium tuberculosis; TB/HIV co-infection; Tuberculosis; Vietnam

Mesh:

Substances:

Year:  2017        PMID: 28743648     DOI: 10.1016/j.jgar.2017.07.003

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  4 in total

1.  Differences in the Structure and Antimicrobial Activity of Hydrazones Derived from Methyl 4-Phenylpicolinimidate.

Authors:  Katarzyna Gobis; Małgorzata Szczesio; Andrzej Olczak; Izabela Korona-Głowniak; Ewa Augustynowicz-Kopeć; Ida Mazernt-Politowicz; Dagmara Ziembicka; Marek L Główka
Journal:  Materials (Basel)       Date:  2022-04-24       Impact factor: 3.748

2.  Severe Clinical Outcomes of Tuberculosis in Kharkiv Region, Ukraine, Are Associated with Beijing Strains of Mycobacterium tuberculosis.

Authors:  Olha Konstantynovska; Mariia Rekrotchuk; Ivan Hrek; Anton Rohozhyn; Nataliia Rudova; Petro Poteiko; Anton Gerilovych; Eric Bortz; Oleksii Solodiankin
Journal:  Pathogens       Date:  2019-06-10

Review 3.  Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives.

Authors:  Abhijeet Singh; Rajendra Prasad; Viswesvaran Balasubramanian; Nikhil Gupta
Journal:  HIV AIDS (Auckl)       Date:  2020-01-13

4.  Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study.

Authors:  Mi Zhou; Shan Liu; Qingfeng Li; Qiming Wang; Ma Zhu; Ling Cao; Dongmei Wang; Yuanhong Xu; Tianli Zheng; Qian Ye; Xiuying Hu; Haojiang Zuo; Xiaofang Pei
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.